Overcoming the challenge of patient compliance with iron chelation therapy.
about
Deferasirox for managing iron overload in people with myelodysplastic syndromeDeferasirox for managing transfusional iron overload in people with sickle cell diseaseDeferasirox for managing iron overload in people with thalassaemiaDeferasirox for managing transfusional iron overload in people with sickle cell diseaseDeferasirox for managing iron overload in people with myelodysplastic syndromeDeferasirox for managing iron overload in people with thalassaemiaDeferasirox for managing iron overload in patients with myelodysplastic syndromeDeferasirox for managing transfusional iron overload in people with sickle cell diseaseIron overload in sickle cell disease.Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions.Deferasirox treatment of iron-overloaded chelation-naïve and prechelated patients with myelodysplastic syndromes in medical practice: results from the observational studies eXtend and eXjange.Toward optimizing the use of deferasirox: potential benefits of combined use with deferoxamineIron chelation therapy in the myelodysplastic syndromes and aplastic anemia: a review of experience in South Korea.Deferasirox: appraisal of safety and efficacy in long-term therapy.β-Thalassemia Intermedia: A Bird's-Eye View.Optimal management of β thalassaemia intermedia.Guidelines for diagnosis and management of Beta-thalassemia intermedia.Deferasirox for managing iron overload in people with thalassaemia.Adherence to desferrioxamine and deferiprone and the impact of deferiprone co-prescription in thalassaemia major patients. Does the addition of deferiprone improve adherence?Approaches to transfusion therapy and iron overload in patients with sickle cell disease: results of an international survey.
P2860
Q24193067-00779723-58D2-454A-A3B4-AC30BE8DEBB2Q24194549-EA038544-B8D7-41F5-A6FB-0920BBD300E6Q24203718-4B369EB3-B0DE-47CA-B003-8E74AE23231AQ24236463-A0BFB5D3-AF4D-4FF4-881C-2C618FB2EF65Q24236532-ED3C4DD9-EBAA-46D1-A1ED-AD8E34F473EDQ24241753-77594D78-2DBF-4F06-B0AE-6FBBB714BC4FQ24242437-5E0D8BEA-18E0-43E2-9E72-3C97E71A8EC1Q24242535-5447BDE1-0330-420E-856B-C95C61DAC90FQ33861129-D4BB4553-E689-4703-9129-497470C67165Q36185410-7D12E751-F39E-403F-9C03-481FFFF9599AQ36420464-9C7FFE40-E26B-44B1-B59D-C93D8EAC077FQ36498403-C4A7B105-5930-4D2A-B9CB-26617231DB65Q36838132-E3D7FDC5-CAFC-4684-9C9F-D62AD3A54B2BQ37095523-F6085C13-95D7-4EC6-B974-B41C6F30C05BQ37718392-2EFCA772-A282-4EE9-8FCC-C8AF325DA4B2Q37830724-7CF9E243-BB92-4F6C-B831-E4558DE1D63BQ38253432-B3D4A41F-B28D-4A90-991C-1238F75FA396Q38624033-F33D3E2A-F041-4949-97AF-D641CEBC36B7Q46552935-D068C03C-BA0D-47A3-94AB-C62C0F8A606AQ53170613-5CA96D69-5F61-405C-B4D3-585285727D20
P2860
Overcoming the challenge of patient compliance with iron chelation therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Overcoming the challenge of patient compliance with iron chelation therapy.
@ast
Overcoming the challenge of patient compliance with iron chelation therapy.
@en
type
label
Overcoming the challenge of patient compliance with iron chelation therapy.
@ast
Overcoming the challenge of patient compliance with iron chelation therapy.
@en
prefLabel
Overcoming the challenge of patient compliance with iron chelation therapy.
@ast
Overcoming the challenge of patient compliance with iron chelation therapy.
@en
P1476
Overcoming the challenge of patient compliance with iron chelation therapy
@en
P2093
Cappellini MD
P304
P356
10.1053/J.SEMINHEMATOL.2005.01.001
P433
P577
2005-04-01T00:00:00Z